News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
206 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (37443)
2025 (32181)
Month
January (4345)
February (4356)
March (4476)
April (4722)
May (4999)
June (4103)
July (3643)
August (3330)
September (4039)
October (5056)
November (4470)
December (3799)
Day
1 (304)
2 (302)
3 (234)
4 (222)
5 (108)
6 (3)
7 (15)
8 (212)
9 (260)
10 (221)
11 (237)
12 (101)
13 (4)
14 (12)
15 (202)
16 (227)
17 (235)
18 (206)
19 (47)
20 (2)
21 (1)
22 (157)
23 (253)
24 (233)
25 (241)
26 (126)
27 (6)
28 (11)
29 (245)
30 (295)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
Deals
Walgreens Boots Alliance Declares Regular Quarterly Dividend of 44 cents per share
Walgreens Boots Alliance, Inc. announced that its board of directors has declared a regular quarterly dividend of 44 cents per share, unchanged from the previous quarter and an increase of 10 percent over the year-ago quarter.
April 18, 2019
·
3 min read
Business
ViewRay Partners with Leading Canadian Distributor to Bring MRI-guided Radiation Therapy to Canada
Minogue Medical to Serve as Exclusive Canadian Distributor for ViewRay’s MRIdian System
April 18, 2019
·
4 min read
FDA
Beckman Coulter’s Early Sepsis Indicator Receives 510(k) Clearance from the U.S. Food and Drug Administration
New hematologic biomarker has the potential to revolutionize clinicians’ approach to sepsis triage and diagnosis
April 18, 2019
·
5 min read
Biotech Beach
MicroVention Announces Positive Safety And Effectiveness Results In Web-It Pivotal Trial Published In Journal Of NeuroInterventional Surgery
The WEB-IT pivotal trial highlights positive clinical outcomes with the WEB® Aneurysm Embolization System, the only intrasaccular flow disruptor approved in the United States.
April 18, 2019
·
4 min read
Deals
American Cancer Society’s Newly Formed Philanthropic Impact Fund Makes First Investment
Convertible note financing of Castle Biosciences, an innovator in skin-cancer diagnostics, is first investment for BrightEdge
April 18, 2019
·
5 min read
Deals
The Medicines Company to Announce First Quarter 2019 Financial Results on April 25
The Medicines Company (NASDAQ:MDCO) will host a conference call and audio webcast on Thursday, April 25, 2019 at 8:30 a.m. EDT to discuss its first quarter 2019 financial results and operational developments.
April 18, 2019
·
1 min read
Business
Encompass Health to present at Bank of America Merrill Lynch Health Care Conference
Encompass Health Corp. announced it will participate in the Bank of America Merrill Lynch Health Care Conference in Las Vegas, Nevada being held May 14-16, 2019.
April 18, 2019
·
1 min read
Business
Philip Morris International Inc. (PMI) Reports 2019 First-Quarter Reported Diluted EPS of $0.87 versus $1.00 in 2018, Reflecting Currency-Neutral Adjusted Diluted EPS Growth of 15.0%
Revises 2019 Full-Year Reported Diluted EPS Forecast to at Least $4.87 versus $5.08 in 2018, Reflecting Currency-Neutral Like-for-Like Adjusted Diluted EPS Growth of at Least 8%
April 18, 2019
·
44 min read
Deals
Sobi™ Publishes 2018 Annual and Sustainability Report
Swedish Orphan Biovitrum AB has released the company’s 2018 Annual and Sustainability Report.
April 18, 2019
·
2 min read
Business
Sartorius Starts off Fiscal 2019 with a Strong First Quarter
Group revenue up 16.8%; order intake up 16.6%; earnings margin1) 26.2%
April 18, 2019
·
9 min read
Previous
6 of 21
Next